Mechanism of Zhinao Capsule in Treating Alzheimer’s Disease Based on Network Pharmacology Analysis and Molecular Docking Validation

Table 2

Results of the molecular docking of four key targets with components.

Target	Component	MOL ID	Binding energy (kcal/mol)
CASP3	Beta-sitosterol	MOL002714	−8.15
CASP3	Naringenin	MOL004328	−7.38
CASP3	Luteolin	MOL000006	−7.34
CASP3	Quercetin	MOL000098	−7.21
CASP3	Baicalein	MOL002714	−7.12
CASP3	Kaempferol	MOL000422	−7.08
TNF-α	Quercetin	MOL000098	−7.97
TNF-α	Kaempferol	MOL000422	−7.58
TNF-α	Luteolin	MOL000006	−7.56
VEGFA	Baicalein	MOL002714	−7.81
VEGFA	Quercetin	MOL000098	−7.56
VEGFA	Diosgenin	MOL000546	−7.39
VEGFA	Luteolin	MOL000006	−7.33
MAPK1	Quercetin	MOL000098	−7.65
MAPK1	Luteolin	MOL000006	−7.44
MAPK1	Naringenin	MOL004328	−7.23